Primary non-adherence to bisphosphonates in an integrated healthcare setting

被引:0
|
作者
K. Reynolds
P. Muntner
T. C. Cheetham
T. N. Harrison
D. E. Morisky
S. Silverman
D. T. Gold
S. S. Vansomphone
R. Wei
C. D. O’Malley
机构
[1] Kaiser Permanente Southern California,Department of Research and Evaluation
[2] University of Alabama at Birmingham,Department of Epidemiology
[3] Kaiser Permanente,Pharmacy Analytical Service
[4] UCLA Fielding School of Public Health,Department of Community Health Sciences
[5] Cedars-Sinai/UCLA,Department of Medicine, Rheumatology Division
[6] Duke University Medical Center,Departments of Psychiatry & Behavioral Sciences, Sociology, and Psychology & Neuroscience
[7] Kaiser Permanente,Pharmacy Analytical Service
[8] Center for Observational Research,undefined
[9] Amgen Inc.,undefined
来源
关键词
Adherence; Bisphosphonates; Postmenopausal osteoporosis; Primary non-adherence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2509 / 2517
页数:8
相关论文
共 50 条
  • [1] Primary non-adherence to bisphosphonates in an integrated healthcare setting
    Reynolds, K.
    Muntner, P.
    Cheetham, T. C.
    Harrison, T. N.
    Morisky, D. E.
    Silverman, S.
    Gold, D. T.
    Vansomphone, S. S.
    Wei, R.
    O'Malley, C. D.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (09) : 2509 - 2517
  • [2] PRIMARY NONADHERENCE TO BISPHOSPHONATES IN AN INTEGRATED HEALTHCARE SETTING
    Reynolds, Kristi
    Muntner, Paul
    Cheetham, T. Craig
    Harrison, Teresa
    Morisky, Donald
    Silverman, Stuart
    Gold, Deborah
    Vansomphone, Southida
    Wei, Rong
    O'Malley, Cynthia
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S52 - S53
  • [3] Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost
    Chodick, Gabriel
    Moser, Sarah Sharman
    Goldshtein, Inbal
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (03) : 359 - 370
  • [4] Primary Non-Adherence in Portugal
    Furtado, Claudia
    Pereira, Joao
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 350 - 351
  • [5] Primary non-adherence in primary care in the Netherlands
    Hempenius, Mirjam
    Rijken, Simone
    Groenwold, Rolf
    de Boer, Anthonius
    Klungel, Olaf H.
    Gardarsdottir, Helga
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 313 - 314
  • [6] The costs of healthcare associated with medication non-adherence
    Ho, P. Michael
    Maddox, Thomas M.
    Shetterly, Susan M.
    Rumsfeld, John S.
    Magid, David J.
    CIRCULATION, 2008, 117 (21) : E460 - E460
  • [7] Primary Non-adherence to Prescribed Medications
    Fischer, Michael A.
    Stedman, Margaret R.
    Lii, Joyce
    Vogeli, Christine
    Shrank, William H.
    Brookhart, M. Alan
    Weissman, Joel S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (08) : 765 - 765
  • [8] Primary Non-adherence to Prescribed Medications
    Andrew J. Karter
    Melissa M. Parker
    Alyce S. Adams
    Howard H. Moffet
    Julie A. Schmittdiel
    Ameena T. Ahmed
    Joe V. Selby
    Journal of General Internal Medicine, 2010, 25 : 763 - 763
  • [9] The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
    Hiligsmann, Mickael
    Rabenda, Veronique
    Bruyere, Olivier
    Reginster, Jean-Yves
    HEALTH POLICY, 2010, 96 (02) : 170 - 177
  • [10] Prediction of non-adherence to oral bisphosphonates using the BMQ 'HARM' score
    Dixon, Christine
    Gardiner, Penny
    MacKay, Kirsten R.
    Horne, Robert
    Viner, Nick J.
    RHEUMATOLOGY, 2008, 47 : II174 - II174